| |
|
|
|
LA Jolla Pharma  
|
|
3.85 0.14 (0.04%) |
08-14 12:14 |
|
Open: |
3.72 |
Pre close: |
3.71 |
Target:
|
5.03
|
|
High: |
3.92 |
Low: |
3.68 |
Resistance:
|
4.31
4.86
|
|
Volume: |
270,073 |
Market Cap: |
105M |
Support:
|
3.41
2.84
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.66
 |
MACD |
MACD(12,26):
|
-0.24 |
|
MA(20): |
3.99  |
Signal(12,26,9): |
-0.25 |
|
MA(100): |
5.39 |
Stochastic Oscillator |
%K(14,3):
|
30.88 |
|
MA(250): |
6.31 |
%D(3): |
19.13 |
|
Average Volume(K) |
3-Month: |
66376
|
52-Week |
High:
|
11.41 |
|
10-Days: |
63235 |
Low: |
2.30 |
|
RSI |
RSI(14):
|
43.56 |
Change(%): |
-61.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.439 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
27.30 |
|
EPS Est. Current Year |
-4.990 |
Return on Assets (ttm) |
-35.0 |
Shares Float (M) |
10.78 |
|
EPS Est. Next Year |
-3.970 |
PEG Ratio |
0.00 |
% Held by Insiders |
5.99 |
|
EPS Est. Next Quarter |
-1.420 |
Qtrly Rev. Growth |
72.7 |
% Held by Institutions |
83.61 |
|
Forward EPS |
-7.850 |
Gross Profit (p.s.) |
0.757 |
Shares Short (K) |
3180 |
|
Book Value (p.s.) |
-2.400 |
EBITDA (p.s.) |
-3.022 |
P/E |
-1.12 |
|
Sales Per Share |
0.962 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-1.61 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-64.51 |
P/S |
4.01 |
|
Operating Margin |
-326.45 |
Levered Free Cash Flow
(M) |
-37.90 |
P/CF |
-1.63 |
|
|
|
|
|
|
